Literature DB >> 22246933

Chordoid glioma in suprasellar location with extension into the third ventricle: smear preparation morphology of a rare tumor.

Nandita Ghosal1, Sumit Thakar, Sunitha P Kumaran, A S Hegde.   

Abstract

We report a rare case of recurrent chordoid glioma in suprasellar region with extension into the third ventricle diagnosed peroperatively. On MRI, a brilliantly contrast enhancing lesion in the suprasellar region extending superiorly into the third ventricle and measuring 2.5 × 3 × 3.5 cm was identified. Patient had a previous history of subtotal removal of the tumor 8 months back and had received 56 Gy of postoperative radiotherapy. On smear preparation the tumor was composed of cells arranged in chords and rows in a myxoid background with sprinkling of lymphocytes. The individual cells were polygonal with moderate amount of faintly eosinophilic cytoplasm with cytoplasmic vacoules in few cells. The nuclei showed fine chromatin with small prominent nucleoli. Paraffin sections confirmed the diagnosis and on immunohistochemistry the tumor cells showed strong positivity for GFAP and focal weak positivity for EMA with low MIB-1 labeling index (<1%). To the best of our knowledge this is the first documented case of chordoid glioma described on crush cytology.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22246933     DOI: 10.1002/dc.21606

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  2 in total

Review 1.  Prognostic factors for recurrence and complications in the surgical management of primary chordoid gliomas: A systematic review of literature.

Authors:  Leonel Ampie; Winward Choy; Jonathan B Lamano; Kartik Kesavabhotla; Qinwen Mao; Andrew T Parsa; Orin Bloch
Journal:  Clin Neurol Neurosurg       Date:  2015-08-19       Impact factor: 1.876

2.  Chordoid glioma: a rare radiologically, histologically, and clinically mystifying lesion.

Authors:  Daniele Bongetta; Andrea Risso; Patrizia Morbini; Giorgio Butti; Paolo Gaetani
Journal:  World J Surg Oncol       Date:  2015-05-28       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.